Cargando…

A potential biomarker for treatment stratification in psychosis: evaluation of an [(18)F] FDOPA PET imaging approach

[(18)F]FDOPA PET imaging has shown dopaminergic function indexed as K(i)(cer) differs between antipsychotic treatment responders and non-responders. However, the theragnostic potential of this biomarker to identify non-responders has yet to be evaluated. In view of this, we aimed to evaluate this as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veronese, Mattia, Santangelo, Barbara, Jauhar, Sameer, D’Ambrosio, Enrico, Demjaha, Arsime, Salimbeni, Hugh, Huajie, Jin, McCrone, Paul, Turkheimer, Federico, Howes, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115068/ https://www.ncbi.nlm.nih.gov/pubmed/32961543 http://dx.doi.org/10.1038/s41386-020-00866-7

Ejemplares similares

An automatic analysis framework for FDOPA PET neuroimaging
por: Nordio, Giovanna, et al.
Publicado: (2023)

Automated Data Quality Control in FDOPA brain PET Imaging using Deep Learning
por: Pontoriero, Antonella D., et al.
Publicado: (2021)

The relationship between grey matter volume and striatal dopamine function in psychosis: a multi-modal (18)F-DOPA PET and voxel-based morphometry study
por: D’Ambrosio, Enrico, et al.
Publicado: (2021)

M18. REDUCED CORTICAL CEREBRAL BLOOD FLOW IN FIRST EPISODE PSYCHOSIS PATIENTS
por: Selvaggi, Pierluigi, et al.
Publicado: (2020)

M149. THE TOPOGRAPHY OF STRIATAL DOPAMINE AND SYMPTOMS IN PSYCHOSIS: AN INTEGRATIVE PET AND MRI STUDY
por: McCutcheon, Rob, et al.
Publicado: (2020)

Determinants of treatment response in first-episode psychosis: an (18)F-DOPA PET study
por: Jauhar, Sameer, et al.
Publicado: (2018)

Reduced cortical cerebral blood flow in antipsychotic-free first-episode psychosis and relationship to treatment response
por: Selvaggi, Pierluigi, et al.
Publicado: (2023)

O3.5. TESTING THE DOPAMINE HYPOTHESIS OF PSYCHOSIS USING POSITRON EMISSION TOMOGRAPHIC IMAGING IN FIRST EPISODE BIPOLAR AFFECTIVE DISORDER AND SCHIZOPHRENIA
por: Jauhar, Sameer, et al.
Publicado: (2018)

The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study
por: Jauhar, Sameer, et al.
Publicado: (2018)

N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study
por: Beck, Katherine, et al.
Publicado: (2021)

Regulation of dopaminergic function: an [(18)F]-DOPA PET apomorphine challenge study in humans.
por: Jauhar, S, et al.
Publicado: (2017)

Correction: Regulation of dopaminergic function: an [(18)F]-DOPA PET apomorphine challenge study in humans
por: Jauhar, S., et al.
Publicado: (2018)

Correction: Regulation of dopaminergic function: An [(18)F]-DOPA PET apomorphine challenge study in humans
por: Jauhar, S, et al.
Publicado: (2019)

The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study
por: Jauhar, Sameer, et al.
Publicado: (2019)

S181. THE STATE OR TRAIT COMPONENT OF DOPAMINE AND GLUTAMATE DYSFUNCTION IN THE RISK FOR PSYCHOSIS: AN IN VIVO MULTIMODAL IMAGING STUDY OF INDIVIDUALS WITH 22Q11.2 DELETION
por: Rogdaki, Maria, et al.
Publicado: (2018)

The Topography of Striatal Dopamine and Symptoms in Psychosis: An Integrative Positron Emission Tomography and Magnetic Resonance Imaging Study
por: McCutcheon, Robert A., et al.
Publicado: (2020)

The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment
por: Jauhar, Sameer, et al.
Publicado: (2023)

Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study
por: Rogdaki, Maria, et al.
Publicado: (2021)

Evaluation of Intraperitoneal [(18)F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity
por: Halff, Els F., et al.
Publicado: (2022)

Cariprazine as a treatment for negative psychotic symptoms in first-episode psychosis: case series
por: Demjaha, Arsime, et al.
Publicado: (2022)

Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia
por: Townsend, Leigh, et al.
Publicado: (2023)

Additive Value of Dynamic FDOPA PET/CT for Glioma Grading
por: Girard, Antoine, et al.
Publicado: (2021)

N-Methyl-D-Aspartate Receptor binding in First-Episode Psychosis: A PET brain imaging study
por: Beck, Katherine, et al.
Publicado: (2021)

Comparison of 6-[(18)F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism
por: Michler, Enrico, et al.
Publicado: (2021)

The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study
por: Rogeau, Antoine, et al.
Publicado: (2022)

Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
por: Pillinger, Toby, et al.
Publicado: (2018)

Correction to: Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
por: Pillinger, Toby, et al.
Publicado: (2018)

The neural and molecular basis of working memory function in psychosis: a multimodal PET-fMRI study
por: Borgan, Faith, et al.
Publicado: (2019)

Glyceryl trinitrate in first-episode psychosis unmedicated with antipsychotics: A randomised controlled pilot study
por: Merritt, Kate, et al.
Publicado: (2020)

42.1 BODY AND MIND: CARDIO-METABOLIC AND IMMUNE FUNCTION IN FIRST EPISODE PSYCHOSIS AND COMPARISON WITH CENTRAL NEUROFUNCTIONAL MEASURES
por: Howes, Oliver, et al.
Publicado: (2018)

T40. GLYCERYL TRINITRATE IN FIRST EPISODE PSYCHOSIS UNMEDICATED WITH ANTIPSYCHOTICS: A RANDOMISED CONTROLLED FEASIBILITY STUDY
por: Merritt, Kate, et al.
Publicado: (2020)

Formal thought disorder in people at ultra-high risk of psychosis
por: Demjaha, Arsime, et al.
Publicado: (2017)

F180. CANNABINOID 1 RECEPTOR AVAILABILITY & MEMORY FUNCTION IN FIRST EPISODE PSYCHOSIS: A MULTI-MODAL PET-FMRI STUDY
por: Borgan, Faith, et al.
Publicado: (2018)

S172. GLUTAMATE RELATED CONNECTIVITY DISTURBANCES OF THE SALIENCE AND DEFAULT MODE NETWORKS IN PSYCHOSIS
por: McCutcheon, Rob, et al.
Publicado: (2020)

Adrenal tracer uptake by (18)F-FDOPA PET/CT in patients with pheochromocytoma and controls
por: Noordzij, Walter, et al.
Publicado: (2019)

Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders
por: Stormezand, Gilles N., et al.
Publicado: (2020)

(18)F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma
por: Tepede, Aisha A, et al.
Publicado: (2020)

Pharmacokinetic Modeling of (18)F-FDOPA PET in the Human Brain for Early Parkinson’s Disease
por: Buratachwatanasiri, Wirunpatch, et al.
Publicado: (2021)

Supervised clustering for TSPO PET imaging
por: Schubert, Julia, et al.
Publicado: (2021)

F18. IS SCHIZOPHRENIA A MULTI-SYSTEM DISORDER? CONSIDERING NEUROLOGICAL, IMMUNE, CARDIOMETABOLIC, AND ENDOCRINE ALTERATIONS IN FIRST EPISODE PSYCHOSIS
por: Pillinger, Toby, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6vir35bd1jarapgaevjijnco50